期刊文献+

抗菌肽修饰方法与抗菌机制的研究进展 被引量:1

Research Progress of Antibacterial Peptide Modified Methods and Antibacterial Mechanism
暂未订购
导出
摘要 抗菌肽,是自然界中存在于众多生物体内对抗外源真菌、细菌及病毒等微生物入侵的天然防御系统主要活性成分。抗菌肽表现出较广的抗菌谱,抗菌机制独特且复杂,不易产生耐药性,被认为是目前多重耐药菌的较佳药物。许多非人源的抗菌肽有免疫原性、溶血反应及半衰期短等问题。研究工作者在原有的抗菌肽基础上,通过不同的修饰,使得抗菌肽的活性提高、毒性降低、制备工艺简化等。同时也有科研工作者,不断进行抗菌肽作用机制的研究,以期为抗菌肽的发现及设计提供更多的可行性借鉴。本文就近三年来,抗菌肽修饰及作用机制的研究进行综述。 The antibacterial peptides, existing naturely in many organisms, was one of main active components of natural defense system against foreign microbial invasion, such as fungi, bacteria ,viruses and so on. Antibacterial peptides showed broad antibacterial spectrum. In addition, antibacterial mechanism was unique and complicated, not easy to produce drug resistance. It is believed that antibacterial peptide is to be better drug to overcome multi-resistant bacteria current. Many non-anthropogenic antimicrobial peptides have some problem, such as immunogenicity, hemolytic reaction, short half-life and so on. Researchers worked on basis of the original antibacterial peptides through different modifiers to improve activity of antimicrobial peptides, descend toxicity and simplify preparation processes, etc, At the same time, some scientific researchers studied the mechanism of antibacterial peptides, so as to provide more feasibility for the discovery and design of new antimicrobial peptides. In this paper, modification and mechanism of action of antibacterial peptide research were reviewed in recent three years.
出处 《国外医药(抗生素分册)》 CAS 2016年第5期193-197,203,共6页 World Notes on Antibiotics
关键词 抗菌肽 修饰 作用机制 antimicrobial peptide modification mechanism of action
  • 相关文献

参考文献28

  • 1Gary T. The bacteria fight back[J]. Science, 2008, 321 (5887):356-361.
  • 2Yeaman MR, and Yount NY. Mechanisms of antimicrobial peptide action and resistance[J]. Pharmacol Rev, 2003, 55(1):27-55.
  • 3The Antimicrobial Peptide Database (APD) [EB/OL]. [2016- 02-22]. http://www, aps. unmc. edu/AP/2016/02/22.
  • 4Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria[J]. Nat Rev Microbiol, 2005, 3(3):238-250.
  • 5Gordon Y J, Romanowski EG, Mcdermott AM. A review of antimicrobial peptides and their therapeutic potential as anti- infective drugs[J]. Current Eye Research, 2005, 30(7):505- 515.
  • 6Dorit A, Yechiel S. Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity[J]. Biochemistry, 2002, 41(7):2254- 2263.
  • 7He M, Krishna K. Antimicrobial activity and protease stability of peptides containing fluorinated amino acids[J]. JACS, 2008, 129(50):15615-15622.
  • 8Radzishevsky IS, Rotem S, Bourdetsky D, et al. Improved antimicrobial peptides based on acyl-lysine oligomers[J]. Nature Biotechnology, 2007, 25(6):657-659.
  • 9Park Y, Park SC, Kim JY, et al. In vitro efficacy of a synthetic all-d antimicrobial peptide against clinically isolated drug-resistant strains[J]. J Antimicrob Agents, 2010, 35(2):208-209.
  • 10Gonz~lez R, Mendive-Tapia L, Pastrian MB, et al. Enhanced antimicrobial activity of a peptide derived from human lysozyme by arylation of its tryptophan residues[J]. J Pep Science, 2016, 22(2):123-128.

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部